Indication
Immunodeficiencies
2 clinical trials
7 products
Clinical trial
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)Status: Recruiting, Estimated PCD: 2024-06-01
Product
BusulfanProduct
FludarabineProduct
Stem cell transplantProduct
KeppraClinical trial
Reduced Intensity Conditioning (RIC) Regimen for Patients With Non-malignant DisordersStatus: Active (not recruiting), Estimated PCD: 2025-12-01
Product
RIC: Distal CampathProduct
RIC:Intermediate CampathProduct
Mini Busulfan